Showing results (101-110 of 193) with videos related to
Sort By:
Pageof 20
Immunogenetics|October 12, 2012
Genetic variation in inflammasome genes is associated with outcome in bacterial meningitisMadelijn Geldhoff, Barry B Mook-Kanamori, Matthijs C Brouwer, et al.Journal of Bacteriology|December 5, 2012
Full genome sequences of all nine Chlamydia psittaci genotype reference strainsSarah Van Lent, Jurgen R Piet, Delphine Beeckman, et al.Acta Neuropathologica Communications|January 7, 2021
Individual responsiveness of macrophage migration inhibitory factor predicts long-term cognitive impairment after bacterial meningitisAnne T Kloek, Mercedes Valls Seron, Ben Schmand, et al.The Journal of Infection|August 14, 2016
Risk scores for outcome in bacterial meningitis: Systematic review and external validation studyMerijn W Bijlsma, Matthijs C Brouwer, Patrick M Bossuyt, et al.Plos Neglected Tropical Diseases|June 15, 2019
Identification of Burkholderia thailandensis with novel genotypes in the soil of central Sierra LeoneEmma Birnie, Senne van 't Hof, Anne Bijnsdorp, et al.BMJ Open|February 12, 2014
Association between population prevalence of smoking and incidence of meningococcal disease in Norway, Sweden, Denmark and the Netherlands between 1975 and 2009: a population-based time series analysisGunnstein Norheim, Manish Sadarangani, Omar Omar, et al.Acta Neuropathologica|November 20, 2013
Plasminogen activator inhibitor-1 influences cerebrovascular complications and death in pneumococcal meningitisMatthijs C Brouwer, Joost C M Meijers, Frank Baas, et al.Emerging Infectious Diseases|October 22, 2015
Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the NetherlandsMirjam J Knol, Gertjan H J Wagenvoort, Elisabeth A M Sanders, et al.Vaccine|January 19, 2016
Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2-6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the NetherlandsGertjan H J Wagenvoort, Elisabeth A M Sanders, Bart J Vlaminckx, et al.Vaccine|December 10, 2015
Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The NetherlandsGertjan H J Wagenvoort, Mirjam J Knol, Hester E de Melker, et al.Pageof 20